Literature DB >> 26183737

Association between autoimmune pancreatitis and malignancy.

Kenji Hirano1, Hiroyuki Isayama, Minoru Tada, Kazuhiko Koike.   

Abstract

Chronic inflammatory diseases are often associated with malignancy, and this phenomenon occurs even in the field of gastroenterology. For example, chronic pancreatitis has been reported to be highly associated with the occurrence of pancreatic cancer. However, the association between autoimmune pancreatitis (AIP) and pancreatic cancer is still an unsolved problem. As AIP is associated with immunoglobulin G4-related disease, which causes a variety of inflammatory and fibrotic lesions, the association between AIP and total malignancies is also a matter of interest. Here, we discuss the association between AIP and malignancy. As for the association between AIP and pancreatic cancer, there is no conclusive evidence, although several reports have suggested that the relative risk of pancreatic cancer is high in AIP. Concerning the association between AIP and total malignancies, there are two reports from Japan. Neither report supported the idea that chronic inflammation in AIP caused the increased risk of total malignancies. However, one report proposed the possibility that AIP might develop as a paraneoplastic syndrome in some patients because many cancers occurred within 1 year of AIP diagnosis, and thereby concluded that patients with AIP were at high risk of having various cancers. The paraneoplastic syndrome hypothesis should be tested in future studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26183737     DOI: 10.1007/s12328-014-0486-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  19 in total

1.  Does autoimmune pancreatitis increase the risk of pancreatic carcinoma?: a retrospective analysis of pancreatic resections.

Authors:  Rajib Gupta; Arezou Khosroshahi; Shweta Shinagare; Carlos Fernandez; Cristina Ferrone; Gregory Y Lauwers; John H Stone; Vikram Deshpande
Journal:  Pancreas       Date:  2013-04       Impact factor: 3.327

2.  K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Shin-Ichirou Horiguchi; Yukiko Hayashi; Xiaoqing Yun; Toshikazu Yamaguchi; Koji Tsuruta; Tsuneo Sasaki
Journal:  J Gastroenterol       Date:  2010-02-16       Impact factor: 7.527

3.  EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer.

Authors:  Asif Khalid; John Dewitt; N Paul Ohori; Jey-Hsin Chen; Kenneth E Fasanella; Michael Sanders; Kevin M McGrath; Marina Nikiforova
Journal:  Pancreatology       Date:  2011-10-11       Impact factor: 3.996

4.  Risk of malignancies in IgG4-related disease.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Tetsuya Tabeya; Chisako Suzuki; Yasuyoshi Naishiro; Keisuke Ishigami; Hidetaka Yajima; Yui Shimizu; Mikiko Obara; Hiroyuki Yamamoto; Tetsuo Himi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Mod Rheumatol       Date:  2011-09-06       Impact factor: 3.023

5.  Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kazumichi Kawakubo; Minoru Tada; Hiroyuki Isayama; Naoki Sasahira; Yousuke Nakai; Keisuke Yamamoto; Hirofumi Kogure; Takashi Sasaki; Kenji Hirano; Hideaki Ijichi; Keisuke Tateishi; Haruhiko Yoshida; Kazuhiko Koike
Journal:  Gut       Date:  2011-03-12       Impact factor: 23.059

6.  Standard steroid treatment for autoimmune pancreatitis.

Authors:  T Kamisawa; T Shimosegawa; K Okazaki; T Nishino; H Watanabe; A Kanno; F Okumura; T Nishikawa; K Kobayashi; T Ichiya; H Takatori; K Yamakita; K Kubota; H Hamano; K Okamura; K Hirano; T Ito; S B H Ko; M Omata
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

7.  Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Kouji Tsuruta; Atsutake Okamoto; Shin-ichirou Horiguchi; Yukiko Hayashi; Xiaoqing Yun; Toshikazu Yamaguchi; Tsuneo Sasaki
Journal:  Pancreas       Date:  2009-11       Impact factor: 3.327

8.  Pancreatitis is a risk factor for pancreatic cancer.

Authors:  P Bansal; A Sonnenberg
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

9.  Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.

Authors:  Tricia A Moo-Young; Justin W Larson; Brian A Belt; Marcus C Tan; William G Hawkins; Timothy J Eberlein; Peter S Goedegebuure; David C Linehan
Journal:  J Immunother       Date:  2009-01       Impact factor: 4.456

10.  Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.

Authors:  Louise K Mercer; Rebecca Davies; James B Galloway; Audrey Low; Mark Lunt; William G Dixon; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Rheumatology (Oxford)       Date:  2013-01       Impact factor: 7.580

View more
  4 in total

1.  Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging.

Authors:  L D Dickerson; A Farooq; F Bano; J Kleeff; R Baron; M Raraty; P Ghaneh; R Sutton; P Whelan; F Campbell; P Healey; J P Neoptolemos; V S Yip
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

Review 2.  IgG4-related Disease - A Systemic Disease that Deserves Attention Regardless of One's Subspecialty.

Authors:  Hideaki Hamano; Eiji Tanaka; Nobukazu Ishizaka; Shigeyuki Kawa
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

3.  Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge.

Authors:  Pei Xiang; Xiaoling Zhang; Chaoyang Wang; Yuejiao Lang; Ling Xu; Li Huang; Jingxian Shen; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2019-08-16       Impact factor: 4.430

Review 4.  Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis.

Authors:  Ayana Okamoto; Tomohiro Watanabe; Ken Kamata; Kosuke Minaga; Masatoshi Kudo
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.